First published · Last updated
Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension with HADHA-associated improvements in fatty acid oxidation and mitochondrial redox homeostasis
Reported by Official source
A journal article published by Elsevier BV reports that spermidine reduced pulmonary arterial hypertension induced by monocrotaline and was associated with HADHA-linked improvements in fatty acid oxidation and mitochondrial redox balance. The article publication date is 2026-11-01.
Share this event
Why it matters
The findings may be relevant to research into treatments for pulmonary arterial hypertension.
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Urgency
- 2/10
Primary official sources
Report an issueRead our editorial process and corrections policy.
Continue exploring
Related developments reported in the last 30 days. These are not necessarily ongoing incidents.
Loading related developments…
Explore event maps
